![Dani Stoltzfus](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dani Stoltzfus
Corporate Officer/Principal presso NEUBASE THERAPEUTICS, INC.
Posizioni attive di Dani Stoltzfus
Società | Posizione | Inizio | Fine |
---|---|---|---|
NEUBASE THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Storia della carriera di Dani Stoltzfus
Formazione di Dani Stoltzfus
Flinders University | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 2 |
Australia | 2 |
Posizioni
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Settori
Health Technology | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
NeuBase Therapeutics, Inc.
![]() NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. The company was founded by Dietrich A. Stephan on March 29, 2002 and is headquartered in Pittsburgh, PA. | Health Technology |
- Borsa valori
- Insiders
- Dani Stoltzfus
- Esperienza